Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
488.74
Dollar change
-3.39
Percentage change
-0.69
%
IndexNDX, S&P 500 P/E31.71 EPS (ttm)15.41 Insider Own0.26% Shs Outstand257.70M Perf Week2.99%
Market Cap126.12B Forward P/E26.91 EPS next Y18.16 Insider Trans-15.34% Shs Float257.37M Perf Month1.50%
Income4.02B PEG2.53 EPS next Q4.17 Inst Own93.04% Short Float1.59% Perf Quarter22.11%
Sales10.17B P/S12.40 EPS this Y11.13% Inst Trans1.21% Short Ratio3.50 Perf Half Y15.33%
Book/sh71.80 P/B6.81 EPS next Y7.30% ROA18.74% Short Interest4.10M Perf Year41.23%
Cash/sh39.42 P/C12.40 EPS next 5Y12.53% ROE24.38% 52W Range340.20 - 495.23 Perf YTD20.12%
Dividend Est.- P/FCF33.93 EPS past 5Y11.42% ROI20.86% 52W High-1.31% Beta0.39
Dividend TTM- Quick Ratio3.29 Sales past 5Y27.16% Gross Margin86.85% 52W Low43.66% ATR (14)8.67
Dividend Ex-Date- Current Ratio3.50 EPS Y/Y TTM22.70% Oper. Margin40.81% RSI (14)65.68 Volatility1.62% 1.84%
Employees5400 Debt/Eq0.04 Sales Y/Y TTM12.74% Profit Margin39.51% Recom1.83 Target Price480.23
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q56.65% Payout0.00% Rel Volume0.72 Prev Close492.13
Sales Surprise4.24% EPS Surprise16.87% Sales Q/Q14.21% EarningsAug 01 AMC Avg Volume1.17M Price488.74
SMA202.65% SMA507.35% SMA20019.21% Trades Volume837,320 Change-0.69%
Date Action Analyst Rating Change Price Target Change
Jun-27-24Initiated Redburn Atlantic Buy $545
Apr-11-24Upgrade Evercore ISI In-line → Outperform $438
Feb-15-24Initiated Wolfe Research Outperform $515
Feb-06-24Downgrade Evercore ISI Outperform → In-line $436 → $438
Feb-02-24Downgrade Bernstein Outperform → Mkt Perform
Jan-31-24Downgrade Robert W. Baird Neutral → Underperform $325
Jan-31-24Downgrade Maxim Group Buy → Hold
Jan-24-24Downgrade Canaccord Genuity Hold → Sell $332 → $379
Dec-14-23Reiterated RBC Capital Mkts Sector Perform $347 → $379
May-30-23Initiated William Blair Outperform $382
Today 09:15AM
Jul-12-24 07:01PM
Jul-11-24 08:45AM
Jul-09-24 06:00PM
07:00AM
08:00AM Loading…
Jul-08-24 08:00AM
06:00AM
Jul-06-24 04:15AM
Jul-05-24 02:14PM
07:45AM
05:45AM
Jul-04-24 05:50AM
Jul-03-24 03:11PM
09:13AM
Jul-02-24 08:33AM
06:24AM Loading…
06:24AM
Jul-01-24 08:40PM
04:05PM
10:02AM
09:30AM
Jun-29-24 03:07AM
Jun-28-24 07:45AM
05:50AM
03:31AM
Jun-27-24 02:21PM
09:54AM
09:04AM
08:00AM
06:40AM
Jun-26-24 04:36PM
09:00AM Loading…
09:00AM
Jun-25-24 04:12AM
Jun-24-24 06:00PM
10:11AM
09:45AM
09:13AM
06:52AM
Jun-21-24 03:45PM
12:00PM
05:51AM
Jun-20-24 07:09PM
Jun-19-24 09:26AM
Jun-18-24 06:00PM
06:50AM
04:30AM
Jun-15-24 06:50AM
Jun-14-24 07:04PM
10:33AM
03:03AM
Jun-13-24 07:00PM
Jun-12-24 05:50PM
09:00AM
07:45AM
Jun-09-24 06:20AM
Jun-07-24 12:00PM
Jun-05-24 07:01PM
11:30AM
Jun-04-24 02:38AM
Jun-03-24 04:24PM
04:17PM
Jun-02-24 06:00AM
05:47AM
Jun-01-24 08:00AM
03:12AM
May-31-24 02:44AM
May-30-24 09:45AM
09:00AM
05:50AM
May-26-24 10:15AM
09:45AM
May-25-24 11:10PM
10:00AM
06:47AM
02:41AM
May-24-24 04:28PM
May-23-24 07:10AM
May-22-24 07:06PM
04:40PM
04:05PM
May-21-24 11:47AM
May-17-24 09:30AM
May-15-24 11:11AM
10:30AM
May-14-24 01:47PM
10:24AM
09:45AM
05:43AM
03:00AM
May-13-24 02:18PM
May-12-24 02:47PM
12:20PM
May-10-24 03:32PM
12:46PM
May-09-24 04:00PM
01:04AM
May-08-24 12:36PM
09:30AM
05:43AM
May-07-24 04:06PM
02:21PM
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bozic CarmenEVP and CMOJul 10 '24Sale487.342,2801,111,13527,819Jul 12 04:07 PM
Bozic CarmenEVP and CMOJun 26 '24Sale471.722,2801,075,52230,099Jun 28 04:04 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Jun 12 '24Sale478.007,2883,483,66415,972Jun 13 04:09 PM
Bozic CarmenEVP and CMOJun 12 '24Sale478.002,2801,089,84032,379Jun 13 04:11 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerJun 03 '24Sale460.003,2501,495,00047,137Jun 05 04:11 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Jun 03 '24Sale460.002,1751,000,50049,098Jun 05 04:08 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.May 31 '24Sale445.002,2501,001,25051,273Jun 03 04:09 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.May 30 '24Sale439.112,3501,031,90853,523Jun 03 04:09 PM
Bozic CarmenEVP and CMOMay 29 '24Sale445.562,2801,015,87734,659May 31 04:19 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerMay 28 '24Sale454.793,2501,478,06850,387May 30 04:07 PM
Kewalramani ReshmaCEO & PresidentMay 24 '24Option Exercise187.531,565293,484122,939May 29 04:08 PM
Kewalramani ReshmaCEO & PresidentMay 24 '24Sale457.001,565715,205121,374May 29 04:08 PM
SACHS BRUCE IDirectorMay 22 '24Option Exercise93.517,073661,39647,073May 24 04:13 PM
SACHS BRUCE IDirectorMay 22 '24Sale448.007,0733,168,70440,000May 24 04:13 PM
Kewalramani ReshmaCEO & PresidentMay 20 '24Sale447.0015,2026,795,294121,374May 22 04:21 PM
Arbuckle Stuart AEVP, COOMay 15 '24Sale430.936929,73449,691May 17 04:24 PM
ALTSHULER DAVIDEVP, Chief Scientific OfficerMay 15 '24Sale430.935423,27025,813May 17 04:22 PM
Sachdev AmitEVP Chief Patient & Ext Af OffMay 15 '24Sale430.933213,79055,325May 17 04:27 PM
Bhatia Sangeeta N.DirectorMay 02 '24Sale402.95467188,1784,435May 03 04:05 PM
Ambrose KristenSVP & Chief Accounting OfficerApr 02 '24Sale419.00240100,5607,500Apr 03 04:02 PM
Arbuckle Stuart AEVP, COOFeb 26 '24Sale425.705,0342,142,97449,691Feb 27 04:37 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 26 '24Sale425.704,2391,804,54225,813Feb 27 04:24 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 26 '24Sale425.703,0041,278,80355,325Feb 27 04:59 PM
Ambrose KristenSVP & Chief Accounting OfficerFeb 26 '24Sale425.70883375,8937,965Feb 27 04:29 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 26 '24Sale425.70883375,89315,972Feb 27 04:44 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 26 '24Sale425.70354150,69855,804Feb 27 05:02 PM
Arbuckle Stuart AEVP, COOFeb 21 '24Sale421.773,6031,519,63759,439Feb 23 04:12 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 21 '24Sale421.773,1911,345,86860,798Feb 23 04:20 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 21 '24Sale421.773,0021,266,15434,022Feb 23 04:10 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 21 '24Sale421.771,201506,54618,509Feb 23 04:16 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 21 '24Sale421.77360151,83759,467Feb 23 04:28 PM
Arbuckle Stuart AEVP, COOFeb 20 '24Sale420.794,8042,021,47563,042Feb 21 04:19 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 20 '24Sale420.794,2541,790,04163,989Feb 21 04:38 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 20 '24Sale420.794,0021,684,00237,024Feb 21 04:13 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 20 '24Sale420.79801337,05319,710Feb 21 04:23 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 20 '24Sale420.79480201,97959,827Feb 21 04:43 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 15 '24Sale419.164,6551,951,19017,896Feb 16 04:07 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 14 '24Sale419.044,3561,825,33822,551Feb 16 04:07 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 13 '24Sale419.13737308,89926,907Feb 14 04:04 PM
Arbuckle Stuart AEVP, COOFeb 12 '24Sale420.244,2951,804,93175,718Feb 13 04:51 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 12 '24Sale420.243,2221,354,01374,364Feb 13 05:15 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 12 '24Sale420.243,1451,321,65547,588Feb 13 04:46 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 12 '24Sale419.512,6561,114,20527,644Feb 14 04:04 PM
Biller JonathanEVP and Chief Legal OfficerFeb 12 '24Sale418.771,738727,82218,280Feb 13 04:56 PM
Ambrose KristenSVP & Chief Accounting OfficerFeb 12 '24Sale420.241,374577,4109,676Feb 13 04:48 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 12 '24Sale420.24913383,67923,137Feb 13 04:54 PM
LEIDEN JEFFREY MExecutive ChairmanJan 08 '24Sale419.076,6482,785,9772,423Jan 10 04:06 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerJan 02 '24Sale405.003,0001,215,00043,693Jan 04 04:17 PM
Kewalramani ReshmaCEO & PresidentDec 15 '23Option Exercise181.8317,1353,115,593125,846Dec 19 04:15 PM
Kewalramani ReshmaCEO & PresidentDec 15 '23Sale407.0017,1356,973,945108,711Dec 19 04:15 PM
Arbuckle Stuart AEVP, COODec 13 '23Option Exercise187.538,6031,613,32165,159Dec 15 04:20 PM
LEIDEN JEFFREY MExecutive ChairmanDec 13 '23Sale399.4213,3545,333,7999,071Dec 15 04:33 PM
Arbuckle Stuart AEVP, COODec 13 '23Sale399.008,6033,432,59756,556Dec 15 04:20 PM
Kewalramani ReshmaCEO & PresidentDec 13 '23Sale397.005,0982,023,906108,711Dec 15 04:23 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerNov 20 '23Sale349.883,0001,049,64046,693Nov 21 04:07 PM
Sachdev AmitEVP Chief Patient & Ext Af OffNov 15 '23Sale369.923512,94758,814Nov 17 04:16 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 15 '23Sale369.92197,02832,038Nov 17 04:11 PM
Bozic CarmenEVP and CMONov 14 '23Sale380.825,6502,151,63329,302Nov 16 04:15 PM
Kewalramani ReshmaCEO & PresidentNov 13 '23Sale377.005,0971,921,569113,809Nov 15 04:16 PM
SACHS BRUCE IDirectorNov 06 '23Option Exercise127.5411,2501,434,82551,250Nov 08 04:11 PM
SACHS BRUCE IDirectorNov 06 '23Sale385.0011,2504,331,25040,000Nov 08 04:11 PM
Bozic CarmenEVP and CMOOct 31 '23Sale355.925,6512,011,30434,952Nov 02 04:07 PM
Bozic CarmenEVP and CMOOct 17 '23Sale373.255,6512,109,23640,603Oct 19 04:18 PM
Bhatia Sangeeta N.DirectorOct 17 '23Sale375.0024391,1253,901Oct 19 04:13 PM
LEIDEN JEFFREY MExecutive ChairmanOct 16 '23Sale374.0012,9624,847,78822,425Oct 18 04:17 PM
Bhatia Sangeeta N.DirectorOct 06 '23Sale360.0024287,1204,144Oct 11 04:14 PM
Bozic CarmenEVP and CMOOct 03 '23Sale345.285,6511,951,17746,254Oct 05 04:30 PM
Biller JonathanEVP and Chief Legal OfficerOct 02 '23Sale346.76610211,52410,569Oct 03 04:07 PM
Bozic CarmenEVP and CMOSep 19 '23Sale351.005,6511,983,50151,905Sep 21 04:15 PM
Bozic CarmenEVP and CMOSep 05 '23Sale352.665,6511,992,88257,556Sep 07 04:29 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Aug 23 '23Sale355.002,500887,50048,637Aug 25 04:14 PM
Kearney Terrence CDirectorAug 10 '23Option Exercise127.5410,0001,275,40016,536Aug 14 04:09 PM
Sachdev AmitEVP, Chief Patient OfficerAug 10 '23Sale350.0010,0313,510,85058,814Aug 14 04:05 PM
Kearney Terrence CDirectorAug 10 '23Sale350.0010,0003,500,0006,536Aug 14 04:09 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Aug 10 '23Sale345.795,7501,988,29351,137Aug 14 04:08 PM
Bhatia Sangeeta N.DirectorAug 09 '23Sale345.5124283,6134,386Aug 11 04:05 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 09 '23Sale345.516321,76732,038Aug 11 04:05 PM
SACHS BRUCE IDirectorJul 17 '23Option Exercise127.5411,2501,434,82551,250Jul 18 04:17 PM
SACHS BRUCE IDirectorJul 17 '23Sale356.7511,2504,013,45940,000Jul 18 04:17 PM
Kewalramani ReshmaCEO & PresidentJul 17 '23Sale355.007,8282,778,940118,906Jul 18 04:13 PM